<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637714</url>
  </required_header>
  <id_info>
    <org_study_id>Probiotics for IBS</org_study_id>
    <nct_id>NCT01637714</nct_id>
  </id_info>
  <brief_title>The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome</brief_title>
  <official_title>The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome: Double-blind, Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      The investigators will evaluate the efficacy of multi-strain probiotics in adults with
      diarrhea predominant irritable bowel syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of Irritable bowel syndrome symptom severity score (IBS-SSS)</measure>
    <time_frame>after 8 weeks</time_frame>
    <description>Severity and frequency of abdominal pain / abdominal bloating / bowel habitus / interfere degree of daily life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool frequency and form</measure>
    <time_frame>after 4 weeks and 8 weeks</time_frame>
    <description>Stool frequency (greater than 3 bowel movements/day or less than 3 bowel movements/week) Stool form (lumpy / hard or loose / watery stool)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom control of irritable bowel syndrome</measure>
    <time_frame>after 4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of overall symptom in patient with irritable bowel syndrome</measure>
    <time_frame>after 4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment for quality of life related with irritable bowel syndrome</measure>
    <time_frame>after 4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment for patient satisfaction after administration completion</measure>
    <time_frame>after 4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Diarrhea Predominant Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Multi-strain probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo powder</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Multi-strain probiotics</intervention_name>
    <description>B. longum BORI: 1 x 109
B. bifidum BGN4: 1 x 109
B. lactis AD011: 1 x 109
B. infantis IBS007: 1 x 109
Lactobacillus acidophilus AD031: 1 x 109
three times a day, within 10 minutes after meal, per oral with water</description>
    <arm_group_label>Multi-strain probiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo powder</intervention_name>
    <description>same taste, shape, dosage as experimental drug
three times a day, within 10 minutes after meal, per oral with water</description>
    <arm_group_label>Placebo powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  willing to consent/undergo necessary procedures

          -  between the age of 19 and 75 years

          -  diarrhea predominant irritable bowel syndrome (satisfied with Rome II criteria)

        Exclusion Criteria:

          -  uncontrolled hypertension (Blood pressure &gt; 180/110 mmHg)

          -  uncontrolled diabetes mellitus (FBS &gt; 200 mg/dL)

          -  malignancy, cerebrovascular disease, cardiovascular disease

          -  history of abdominal surgery except appendectomy and hernia repair

          -  inflammatory bowel disease

          -  clinically or laboratory-confirmed gastroenteritis

          -  the use of motility drug or dietary fiber supplement in 2 weeks

          -  serum Cr &gt; 2 x Upper normal limit

          -  AST or ALT &gt; 2 x Upper normal limit

          -  Pregnancy, Lactating woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joo Sung Kim, M.D.,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joo Sung Kim, M.D., PhD</last_name>
    <phone>+82-2-740-8112</phone>
    <email>jooskim@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kyoung Sup Hong, M.D.</last_name>
    <phone>+82-10-2578-5738</phone>
    <email>kshong1@empas.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joo Sung Kim, M.D.,PhD</last_name>
      <phone>+82-2-740-8112</phone>
      <email>jooskim@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Kyoung Sup Hong, M.D.</last_name>
      <phone>+82-10-2578-5738</phone>
      <email>kshong1@empas.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2012</study_first_submitted>
  <study_first_submitted_qc>July 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2012</study_first_posted>
  <last_update_submitted>June 17, 2013</last_update_submitted>
  <last_update_submitted_qc>June 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

